Overview

A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.

Status:
Completed
Trial end date:
2020-08-10
Target enrollment:
Participant gender:
Summary
Study to evaluate the effect of pf-06651600 on pharmacokinetics of single dose sumatriptan.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Sumatriptan